RECRUITING

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Description

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasibility and effectiveness of the adapted PPC framework in breast cancer survivorship for older adults.

Conditions

Breast Cancer Survivorship
Talk to us

Related Conditions:

Breast Cancer Survivorship

Study Overview

On this page

Study Details

Study overview

The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasibility and effectiveness of the adapted PPC framework in breast cancer survivorship for older adults.

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Condition
Breast Cancer Survivorship
Intervention / Treatment

-

Contacts and Locations

Bellaire

UT Physicians Center for Healthy Aging Bellaire, Bellaire, Texas, United States, 77401

Houston

UT Physicians Family Medicine Bayshore, Houston, Texas, United States, 77006

Houston

Memorial Hermann Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * able to write and speak English
  • * Stage DCIS/I/II/III breast cancer diagnosis
  • * 3 months from active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment) up to 10 years since completing treatment
  • * ≥3 documented comorbidities by chart review, or taking ≥10 medications, have ≥ 1 hospitalization over the past year, ≥ 2 emergency department visits over the past year, seen by \> 2 specialists over the past year
  • * able to provide consent
  • * currently on active cancer therapy (including first or second-line treatment chemotherapy, radiation and/or surgery, or multimodal treatment)

Ages Eligible for Study

65 Years to 100 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

The University of Texas Health Science Center, Houston,

Dana E. Giza, MD, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

2027-06-01